Adempas Tablets and Carbidopa and Levodopa Extended-Release Tablets
Determining the interaction of Adempas Tablets and Carbidopa and Levodopa Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: riociguat
Brand name: Adempas
Synonyms: Riociguat
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adempas Tablets-Carbidopa and Levodopa ODT
- Adempas Tablets-Carbidopa and Levodopa Orally Disintegrating Tablets
- Adempas Tablets-Carbidopa and levodopa Route Not Applicable
- Adempas Tablets-Carbidopa and Levodopa Tablets
- Adempas Tablets-Carbidopa Tablets
- Adempas Tablets-Carbidopa, entacapone, and levodopa
- Carbidopa and Levodopa Extended-Release Tablets-Adenocard
- Carbidopa and Levodopa Extended-Release Tablets-Adenoscan
- Carbidopa and Levodopa Extended-Release Tablets-Adenosine
- Carbidopa and Levodopa Extended-Release Tablets-Adenosine Intravenous
- Carbidopa and Levodopa Extended-Release Tablets-Adenovirus Type 4 and Type 7 Vaccine Live Oral
- Carbidopa and Levodopa Extended-Release Tablets-Adenovirus Vaccine